Exor Capital LLP
- SEC CIK
- 0001732768
- Latest filing
- Jul 29, 2026
INDV holding history
Indivior Pharmaceuticals, Inc. in every 13F filed by Exor Capital LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INDV overviewAll 13F holders of INDVFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −474,000−100.0% | Sold out | Holders |
| Q2 2024 | 474,000 | $7.43M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 474,000 | $10.1M | 0.4% | −116,000−19.7% | Reduced | Holders |
| Q4 2023 | 590,000 | $8.91M | 0.4% | +316,435+115.7% | Added | Holders |
| Q3 2023 | 273,565 | $5.94M | 0.3% | +273,565 | New | Holders |